Ken Griffin Third Harmonic Bio, Inc. Call Options Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

Call Options

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2024 Nov 14, 2024	SELL	$10.86 - $15.0 $21,720 - $30,000	-2,000 Reduced 21.98%	7,100 $96,000
Q2 2024 Aug 14, 2024	BUY	$8.74 - $15.54 $79,534 - $141,414	9,100 New	9,100 $118,000

Others Institutions Holding THRD

# of Institutions

83

Shares Held

43.6M

Call Options Held

7.1K

Put Options Held

0

Atlas Venture Life Science Advisors, LLC

10.9M
Shares

$113 Million
18.24% of portfolio
Orbimed Advisors LLC San Diego, CA

5.78M
Shares

$59.6 Million
1.85% of portfolio
Bvf Inc San Francisco, CA

4.37M
Shares

$45.1 Million
1.88% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.18M
Shares

$32.8 Million
1.87% of portfolio
General Atlantic LLC New York, NY

2.96M
Shares

$30.5 Million
1.15% of portfolio

About Third Harmonic Bio, Inc.

Ticker THRD
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,328,900
Market Cap $416M

More about THRD

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.